|
|
|
Volumn 6, Issue 8, 2000, Pages 2967-2968
|
|
Can O6-Alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 O ALKYLGUANINE DNA ALKYLTRANSFERASE;
6 O BENZYLGUANINE;
ALKYL GROUP;
CARMUSTINE;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
GUANINE;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
O(6) BENZYLGUANINE;
O(6)-BENZYLGUANINE;
BONE MARROW SUPPRESSION;
DOSE RESPONSE;
DRUG TOLERABILITY;
EDITORIAL;
LYMPHOMA;
PRIORITY JOURNAL;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
ENZYME ACTIVATION;
HUMAN;
METABOLISM;
NOTE;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARMUSTINE;
DRUG SYNERGISM;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
GUANINE;
HUMANS;
O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;
|
|
EID: 0033624176
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (18)
|
|
References (5)
|
